The EMRA offices will be closed for the upcoming holidays from Wednesday, December 24, 2025 until Monday, January 5, 2026. We apologize for the inconvenience.
Released in October 2019, CRASH-3 is the latest trial exploring the benefits of tranexamic acid, this time in traumatic brain injury. The bottom line: TXA hasn't been shown to reduce mortality.